Evidence map›Paper›PMID 25875769›Full record

ArticlePloS one2015

Specific cellular incorporation of a pyrene-labelled cholesterol: lipoprotein-mediated delivery toward ordered intracellular membranes.

Gérald Gaibelet, Sophie Allart, François Tercé, Vincent Azalbert, Justine Bertrand-Michel, Safouane Hamdi, Xavier Collet, Stéphane Orlowski

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Exploring epigenetic and microRNA approaches for γ-globin gene regulation.Experimental biology and medicine (Maywood, N.J.) · 2021
    Review
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Gérald GaibeletINSERM U563/1048, CHU Purpan, 31024, Toulouse, cedex 3, France; CEA, SB2SM and UMR8221/UMR9198 CNRS, I2BC, IBiTec-Saclay, 91191, Gif-sur-Yvette, cedex, France; Université Toulouse III, UMR 1048, F-31000, Toulouse, France.
Sophie AllartUniversité Toulouse III, UMR 1048, F-31000, Toulouse, France; Plateau technique d'Imagerie Cellulaire, INSERM U1043, F-31300, Toulouse, France.
François TercéUniversité Toulouse III, UMR 1048, F-31000, Toulouse, France; INSERM U1048, F-31400, Toulouse, France.
Vincent AzalbertUniversité Toulouse III, UMR 1048, F-31000, Toulouse, France; INSERM U1048, F-31400, Toulouse, France.
Justine Bertrand-MichelUniversité Toulouse III, UMR 1048, F-31000, Toulouse, France; INSERM U1048, Lipidomic Platform Metatoul, F-31400, Toulouse, France.
Safouane HamdiINSERM U563/1048, CHU Purpan, 31024, Toulouse, cedex 3, France.
Xavier ColletUniversité Toulouse III, UMR 1048, F-31000, Toulouse, France; INSERM U1048, F-31400, Toulouse, France.
Stéphane OrlowskiINSERM U563/1048, CHU Purpan, 31024, Toulouse, cedex 3, France; CEA, SB2SM and UMR8221/UMR9198 CNRS, I2BC, IBiTec-Saclay, 91191, Gif-sur-Yvette, cedex, France.
Université Toulouse III - Paul Sabatier · FRUniversité Fédérale de Toulouse Midi-Pyrénées · FRHôpital Purpan · FRInserm · FRInstitut de Biologie et Technologies · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the aim of testing tools for tracing cell trafficking of exogenous cholesterol, two fluorescent derivatives of cholesterol, 22-nitrobenzoxadiazole-cholesterol (NBD-Chol) and 21-methylpyrenyl-cholesterol (Pyr-met-Chol), with distinctive chemico-physical characteristics, have been compared for their cell incorporation properties, using two cell models differently handling cholesterol, with two incorporation routes. In the Caco-2 cell model, the cholesterol probes were delivered in bile salt micelles, as a model of intestinal absorption. The two probes displayed contrasting behaviors for cell uptake characteristics, cell staining, and efflux kinetics. In particular, Pyr-met-Chol cell incorporation involved SR-BI, while that of NBD-Chol appeared purely passive. In the PC-3 cell model, which overexpresses lipoprotein receptors, the cholesterol probes were delivered via the serum components, as a model of systemic delivery. We showed that Pyr-met-Chol-labelled purified LDL or HDL were able to specifically deliver Pyr-met-Chol to the PC-3 cells, while NBD-Chol incorporation was independent of lipoproteins. Observations by fluorescence microscopy evidenced that, while NBD-Chol readily stained the cytosolic lipid droplets, Pyr-met-Chol labelling led to the intense staining of intracellular structures of membranous nature, in agreement with the absence of detectable esterification of Pyr-met-Chol. A 48 h incubation of PC-3 cells with either Pyr-met-Chol-labelled LDL or HDL gave same staining patterns, mainly colocalizing with Lamp1, caveolin-1 and CD63. These data indicated convergent trafficking downwards their respective receptors, LDL-R and SR-BI, toward the cholesterol-rich internal membrane compartments, late endosomes and multivesicular bodies. Interestingly, Pyr-met-Chol staining of these structures exhibited a high excimer fluorescence emission, revealing their ordered membrane environment, and indicating that Pyr-met-Chol behaves as a fair cholesterol tracer regarding its preferential incorporation into cholesterol-rich domains. We conclude that, while NBD-Chol is a valuable marker of cholesterol esterification, Pyr-met-Chol is a reliable new lipoprotein fluorescent marker which allows to probe specific intracellular trafficking of cholesterol-rich membranes.

Indexed as

Biological TransportCaco-2 CellsCell MembraneCholesterolHumansLipoproteins, HDLLipoproteins, LDLPyrenesCholesterolLipoproteins, HDLLipoproteins, LDLpyrenePyrenes

Identifiers

PMID25875769
PMCPMC4398402
OpenAlexW2090510320

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.